EMULATE THERAPEUTICS, INC.
SEATTLE, WA · CIK 0001254348 · Biotech · Private
Ultra-low radio frequency energy delivery system to modulate cell behavior for therapeutic applications
emulatetx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $12M
- 7 Form D · Sep 2019
- 84 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 1 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $300,000 | |
| Private capital raised | Form D · SEC | $9,161,414 | |
| Private capital raised | Form D · SEC | $725,000 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $210,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $450,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2281 | EFFECTORBIO, INC. | — | — |
| 2282 | Ensysce Biosciences, Inc. | — | $103M |
| 2283 | VIACYTE, INC. | — | $150M |
| 2284 | EMULATE THERAPEUTICS, INC. | — | $12M |
| 2285 | Dicerna Pharmaceuticals, Inc. | — | $90M |
| 2286 | CytoDyn Inc. | — | $88M |
| 2287 | Geneoscopy, Inc. | — | $58M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bennett ButtersDirector
- Lisa ButtersDirector
- John ButtersDirector · Executive Officer
- JOHN BUTTERSDirector · Executive Officer
- BENNETT BUTTERSDirector
- LISA BUTTERSDirector · Executive Officer
- ANDY DANIELSDirector
- Clark DonnellDirector
- CLARK DONNELLDirector
- Dave GriegerDirector
- David GriegerDirector
- DAVID GRIEGERDirector
- DICK HENRIQUESDirector
- Sean KellDirector
- SEAN KELLDirector
- John KingmaDirector
- JOHN KINGMADirector · Executive Officer
- Daniel KisnerDirector
- DANIEL KISNERDirector
- Charles McNerneyDirector
- CHARLES MCNERNEYDirector
- Nancy NordhoffDirector
- NANCY NORDHOFFDirector
- John PayneDirector
- Steven PopeExecutive Officer
- STEVEN POPEExecutive Officer
- Chris RiveraDirector · Executive Officer
- CHRIS RIVERADirector · Executive Officer
- UNA RYANDirector
- MICHAEL ULLMANDirector
Patents
- Methods For Treating Glioblastoma Or Recurrent Glioblastoma Utilizing A Wireless Signal Alone Or In Combination With One Or More Cancer Drugs, And Associated Systems, Apparatuses, And Devicesapplication
- Controller And Flexible Coils For Administering Therapy, Such As For Cancer Therapyapplication
- Controller And Flexible Coils For Administering Therapy, Such As For Cancer Therapyapplication
- Methods For Treating Glioblastoma Or Recurrent Glioblastoma Utilizing A Wireless Signal Alone Or In Combination With One Or More Cancer Drugs, And Associated Systems, Apparatuses, And Devicesapplication
- Analgesia Via Low And Ultra-low Frequency Magnetic Or Electromagnetic Fields And Related Systems And Methodsapplication
- Non-intrusive Delivery Mechanism For Producing Physiological Effects In Living Organismsapplication
- Therapeutic Energy Emission Headbandgranted
- Methods For Treating Glioblastoma Or Recurrent Glioblastoma Utilizing A Wireless Signal Alone Or In Combination With One Or More Cancer Drugs, And Associated Systems, Apparatuses, And Devicesapplication
- Non-intrusive Delivery Mechanism For Producing Physiological Effects In Living Organismsapplication
- Analgesia Via Low And Ultra-low Frequency Magnetic Or Electromagnetic Fields And Related Systems And Methodsapplication
- Non-intrusive Delivery Mechanism For Producing Physiological Effects In Living Organismsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.